Frequently Asked Questions about Satellos Bioscience Inc. (MSCLF)

Name: Satellos Bioscience Inc. (MSCLF) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Satellos Bioscience Inc. (MSCLF) do?

Accepted Answer

Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The ...

Question 2

Is Satellos Bioscience Inc. (MSCLF) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of MSCLF reveals an Altman Z-Score of 14.00 and a Piotroski F-Score of 2/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if MSCLF fits their risk profile.

Question 3

What is the current P/E ratio for MSCLF?

Accepted Answer

As of the latest trading session, Satellos Bioscience Inc. (MSCLF) has a trailing P/E ratio of -1.76.

Question 4

Who is the CEO of Satellos Bioscience Inc.?

Accepted Answer

The current Chief Executive Officer of Satellos Bioscience Inc. is Francis Gleeson.

Question 5

What was MSCLF's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Satellos Bioscience Inc. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does MSCLF pay a dividend?

Accepted Answer

Satellos Bioscience Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does MSCLF have?

Accepted Answer

In its latest reporting period, Satellos Bioscience Inc. generated $-0.02B in Free Cash Flow against a total debt load of $N/A.

Question 8

What is the Price-to-Book (P/B) ratio of Satellos Bioscience Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Satellos Bioscience Inc. (MSCLF) is currently 0.49.

Question 9

What is the Price-to-Sales (P/S) ratio of MSCLF?

Accepted Answer

Based on trailing twelve-month data, Satellos Bioscience Inc. (MSCLF) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Satellos Bioscience Inc.'s Return on Equity (ROE)?

Accepted Answer

Satellos Bioscience Inc. (MSCLF) has a Return on Equity (ROE) of -51.42%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	-23.6M	3.2M	-6K	-23.6M	-26.8M
2024-12	-25M	2.1M	-6K	-25M	-27.1M
2023-12	-14.5M	2.2M	-18K	-14.5M	-16.7M
2022-12	-5.7M	1.4M	-3.5K	-5.7M	-7.2M
2021-12	-5M	971.5K	-7.2K	-5M	-6M